Diuretic Medications

  • Donald Berry
  • Traci M. Kazmerski

Furosemide is most commonly used in the management of edema during congestive heart failure (CHF) and hepatic or renal disease. Frequently, it is the diuretic of choice to treat postoperative edema after cardiac surgery. It may also be used in the treatment of hypertensive patients1 alone or in combination with other antihypertensive medications.


Loop Diuretic Metabolic Alkalosis Ethacrynic Acid Distal Convoluted Tubule Monitoring Parameter 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Puschett, J. (2000). “Diuretics and the therapy of hypertension”. Am J Med Sci 319(1): 1–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Prandota, J. (2001). “Clinical pharmacology of furosemide in children: a supplement”. Am J Ther 8(4): 275–289.PubMedCrossRefGoogle Scholar
  3. 3.
    Govindarajan, G., Q. Bashir, S. Kuppuswamy, and C. Brooks (2005). “Sweet syndrome associated with furosemide”. South Med J 98(5): 570–572.PubMedCrossRefGoogle Scholar
  4. 4.
    Schwartz, J., R. Bloch, J. Imbs, and M. Spach (1986). “[Diuretics]”. Pathol Biol (Paris) 34(7): 861–885.Google Scholar
  5. 5.
    Sica, D. (2003). “Metolazone and its role in edema management”. Congest Heart Fail 9(2): 100–105.PubMedCrossRefGoogle Scholar
  6. 6.
    Materson, B. (1983). “Insights into intrarenal sites and mechanisms of action of diuretic agents”. Am Heart J 106(1 Pt 2): 188–208.Google Scholar
  7. 7.
    Ritland, J., K. Egge, S. Lydersen, R. Juul, and S. Semb (2004). “Comparison of survival of exfoliative glaucoma patients and primary open-angle glaucoma patients: impact of acetazolamide use”. Acta Ophthalmol Scand 82(4): 397–400.PubMedCrossRefGoogle Scholar
  8. 8.
    Poca, M. and J. Sahuquillo (2005). “Short-term medical management of hydrocephalus”. Expert Opin Pharmacother 6(9): 1525–1538.PubMedCrossRefGoogle Scholar
  9. 9.
    Brilla, C., M. Schencking, C. Scheer and H. Rupp (1997). “[Spironolactone: renaissance of anti-aldosterone therapy in heart failure?]”. Schweiz Rundsch Med Prax. 86(14): 566–574.Google Scholar
  10. 10.
    Borges, H., J. Hocks, and C. Kjellstrand (1982). “Mannitol intoxication in patients with renal failure”. Arch Intern Med 142(1): 63–66.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2008

Authors and Affiliations

  • Donald Berry
    • 1
  • Traci M. Kazmerski
    • 2
  1. 1.Pharmacy DepartmentChildren's Hospital of PittsburghPittsburghUSA
  2. 2.Cardiac Intensive Care UnitChildren's Hospital of PittsburghPittsburghUSA

Personalised recommendations